CareDx (CDNA) Competitors $20.61 +0.06 (+0.29%) (As of 12/20/2024 05:31 PM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends CDNA vs. GH, OPCH, SHC, VCYT, BTSG, LFST, SGRY, CON, PRVA, and ARDTShould you be buying CareDx stock or one of its competitors? The main competitors of CareDx include Guardant Health (GH), Option Care Health (OPCH), Sotera Health (SHC), Veracyte (VCYT), BrightSpring Health Services (BTSG), LifeStance Health Group (LFST), Surgery Partners (SGRY), Concentra Group Holdings Parent (CON), Privia Health Group (PRVA), and Ardent Health Partners (ARDT). These companies are all part of the "healthcare" industry. CareDx vs. Guardant Health Option Care Health Sotera Health Veracyte BrightSpring Health Services LifeStance Health Group Surgery Partners Concentra Group Holdings Parent Privia Health Group Ardent Health Partners CareDx (NASDAQ:CDNA) and Guardant Health (NASDAQ:GH) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their analyst recommendations, community ranking, risk, profitability, valuation, dividends, institutional ownership, earnings and media sentiment. Is CDNA or GH more profitable? CareDx has a net margin of -45.90% compared to Guardant Health's net margin of -74.02%. CareDx's return on equity of -53.70% beat Guardant Health's return on equity.Company Net Margins Return on Equity Return on Assets CareDx-45.90% -53.70% -30.42% Guardant Health -74.02%-1,200.44%-29.88% Do analysts prefer CDNA or GH? CareDx currently has a consensus price target of $29.60, indicating a potential upside of 43.62%. Guardant Health has a consensus price target of $40.60, indicating a potential upside of 28.20%. Given CareDx's higher probable upside, equities analysts plainly believe CareDx is more favorable than Guardant Health.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score CareDx 1 Sell rating(s) 2 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.43Guardant Health 0 Sell rating(s) 0 Hold rating(s) 15 Buy rating(s) 0 Strong Buy rating(s) 3.00 Do insiders & institutionals believe in CDNA or GH? 92.6% of Guardant Health shares are held by institutional investors. 4.9% of CareDx shares are held by company insiders. Comparatively, 5.5% of Guardant Health shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term. Which has higher earnings and valuation, CDNA or GH? CareDx has higher earnings, but lower revenue than Guardant Health. CareDx is trading at a lower price-to-earnings ratio than Guardant Health, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCareDx$312.78M3.53-$190.28M-$2.70-7.63Guardant Health$692.26M5.65-$479.45M-$4.24-7.47 Does the media prefer CDNA or GH? In the previous week, Guardant Health had 5 more articles in the media than CareDx. MarketBeat recorded 14 mentions for Guardant Health and 9 mentions for CareDx. CareDx's average media sentiment score of 1.05 beat Guardant Health's score of 0.56 indicating that CareDx is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment CareDx 6 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Guardant Health 7 Very Positive mention(s) 0 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Does the MarketBeat Community believe in CDNA or GH? CareDx received 159 more outperform votes than Guardant Health when rated by MarketBeat users. However, 70.07% of users gave Guardant Health an outperform vote while only 66.17% of users gave CareDx an outperform vote. CompanyUnderperformOutperformCareDxOutperform Votes44066.17% Underperform Votes22533.83% Guardant HealthOutperform Votes28170.07% Underperform Votes12029.93% Which has more volatility & risk, CDNA or GH? CareDx has a beta of 1.84, meaning that its stock price is 84% more volatile than the S&P 500. Comparatively, Guardant Health has a beta of 1.26, meaning that its stock price is 26% more volatile than the S&P 500. SummaryGuardant Health beats CareDx on 10 of the 18 factors compared between the two stocks. Ad Crypto Swap ProfitsURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year. This is where fortunes are made – often LITERALLY overnight.>> Register for the Workshop Now Get CareDx News Delivered to You Automatically Sign up to receive the latest news and ratings for CDNA and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CDNA vs. The Competition Export to ExcelMetricCareDxMedical laboratories IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.11B$2.93B$5.12B$9.07BDividend YieldN/A15.63%4.91%4.22%P/E Ratio-7.6316.0291.3417.19Price / Sales3.53284.461,117.70116.80Price / CashN/A472.1142.6437.86Price / Book4.275.194.794.78Net Income-$190.28M-$32.86M$120.07M$225.60M7 Day Performance-9.84%-3.01%-1.90%-1.23%1 Month Performance-8.48%2.96%11.45%3.37%1 Year Performance76.30%12.37%30.63%16.58% CareDx Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CDNACareDx3.591 of 5 stars$20.61+0.3%$29.60+43.6%+90.5%$1.11B$312.78M-7.63740Positive NewsHigh Trading VolumeGHGuardant Health4.1134 of 5 stars$34.89+0.4%$40.60+16.4%+25.6%$4.31B$692.26M-8.201,779OPCHOption Care Health4.8647 of 5 stars$23.40-0.4%$30.14+28.8%-29.9%$3.98B$4.78B19.747,802Positive NewsSHCSotera Health3.5856 of 5 stars$12.98-1.3%$16.08+23.9%-20.0%$3.68B$1.05B52.603,000Positive NewsVCYTVeracyte4.0328 of 5 stars$43.27+0.1%$41.13-5.0%+49.0%$3.35B$361.05M-288.13790Positive NewsBTSGBrightSpring Health Services2.312 of 5 stars$18.94+2.0%$18.50-2.3%N/A$3.30B$10.59B-71.3835,000Analyst ForecastLFSTLifeStance Health Group1.6908 of 5 stars$7.75+8.1%$8.70+12.3%-0.3%$2.97B$1.21B-29.509,325Positive NewsGap UpSGRYSurgery Partners3.2411 of 5 stars$22.17+8.9%$36.56+64.9%-33.8%$2.82B$2.74B-42.4213,500Positive NewsCONConcentra Group Holdings ParentN/A$21.54+5.1%$28.50+32.3%N/A$2.74B$1.88B0.0011,000Gap UpPRVAPrivia Health Group2.8913 of 5 stars$21.42+2.2%$24.80+15.8%-12.6%$2.57B$1.66B209.621,102ARDTArdent Health PartnersN/A$16.89+1.2%$21.82+29.2%N/A$2.41B$5.41B0.0024,200Analyst ForecastPositive News Related Companies and Tools Related Companies Guardant Health Alternatives Option Care Health Alternatives Sotera Health Alternatives Veracyte Alternatives BrightSpring Health Services Alternatives LifeStance Health Group Alternatives Surgery Partners Alternatives Concentra Group Holdings Parent Alternatives Privia Health Group Alternatives Ardent Health Partners Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:CDNA) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredVideo: Blindfolded Man Gets Into a Cybertruck… What Happens Next Will Shock You“Hi, I’m Jeff Brown… Even though I can’t see a thing… I’m about to get in this Cybertruck and drive up t...Brownstone Research | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CareDx, Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share CareDx With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CDNA Stock Alerts